Purple Biotech (PPBT) Short Interest Ratio & Short Volume $2.54 +0.03 (+1.20%) (As of 11:15 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Purple Biotech Short Interest DataPurple Biotech (PPBT) has a short interest of 19,500 shares, representing 1.08% of the float (the number of shares available for trading by the public). This marks a 8.33% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 18,481 shares to cover all short positions.Current Short Interest19,500 sharesPrevious Short Interest18,000 sharesChange Vs. Previous Month+8.33%Dollar Volume Sold Short$62,595.00Short Interest Ratio0.5 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,330,000 sharesFloat Size1,800,000 sharesShort Percent of Float1.08%Today's Trading Volume5,836 sharesAverage Trading Volume18,481 sharesToday's Volume Vs. Average32% Short Selling Purple Biotech? Sign up to receive the latest short interest report for Purple Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPPBT Short Interest Over TimePPBT Days to Cover Over TimePPBT Percentage of Float Shorted Over Time Ad Behind the MarketsDylan Jovine's #1 Retirement Play for 2024Register: My First LIVE Event in 5 Years! On Tuesday, November 19th, I'm breaking my "no webinars" rule and going LIVE at 8:00pm Eastern. You won't want to miss this event. I'm releasing my No. 1 Retirement Play in 2024. It has nothing to do with regular stocks, options, cryptos or any investment fads.Click here now to register for "Our #1 Takeover Target for November" event. Purple Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202419,500 shares $62,595.00 +8.3%1.1%0.5 $3.21 10/15/202418,000 shares $74,520.00 +37.4%1.0%0.8 $4.14 9/30/202413,100 shares $72,967.00 -33.5%0.8%0.6 $5.57 9/15/202419,700 shares $0.00 -95.3%1.2%1 $0.00 8/31/2024418,800 shares $204,793.20 +28.5%N/A1.5 $0.49 8/15/2024326,000 shares $120,587.40 -14.1%N/A1.1 $0.37 Get the Latest News and Ratings for PPBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Purple Biotech and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024379,700 shares $146,458.64 -6.1%N/A1.3 $0.39 7/15/2024404,500 shares $153,790.90 -48.9%N/A1.2 $0.38 6/30/2024790,900 shares $321,896.30 +188.7%N/A2.3 $0.41 6/15/2024274,000 shares $164,674.00 -11.6%N/A1.5 $0.60 5/31/2024309,900 shares $250,244.25 +20.3%N/A1.7 $0.81 5/15/2024257,600 shares $128,800.00 -13.3%N/A1.5 $0.50 4/30/2024297,200 shares $153,860.44 +27.3%N/A2 $0.52 4/15/2024233,500 shares $132,324.45 +5.1%N/A2 $0.57 3/31/2024222,200 shares $148,874.00 -0.4%N/A2.3 $0.67 3/15/2024223,000 shares $161,641.55 -24.6%N/A2.2 $0.72 2/29/2024295,900 shares $249,857.96 -6.2%N/A2.9 $0.84 2/15/2024315,400 shares $239,672.46 -24.6%N/A3.5 $0.76 1/31/2024418,100 shares $275,946.00 -7.7%N/A5.2 $0.66 1/15/2024452,800 shares $312,432.00 -4.7%N/A4.6 $0.69 12/31/2023475,100 shares $370,578.00 -13.5%N/A4.6 $0.78 12/15/2023548,900 shares $521,455.00 +7.8%N/A5.2 $0.95 11/30/2023509,100 shares $529,464.00 -8.6%N/A5.6 $1.04 11/15/2023556,700 shares $578,968.00 -20.5%N/A6.4 $1.04 10/31/2023700,100 shares $945,135.00 -6.5%N/A8.1 $1.35 10/15/2023748,400 shares $950,468.00 +15.9%N/A9.5 $1.27 9/30/2023645,900 shares $768,621.00 -0.1%N/A7.1 $1.19 9/15/2023646,600 shares $724,192.00 -4.7%N/A7.5 $1.12 8/31/2023678,400 shares $820,864.00 -0.5%N/A7.7 $1.21 8/15/2023681,600 shares $763,392.00 -2.5%N/A8 $1.12 7/31/2023698,700 shares $761,583.00 -11.3%N/A8.5 $1.09 7/15/2023787,900 shares $961,238.00 +17.2%N/A11.2 $1.22 6/30/2023672,100 shares $937,579.50 -0.5%N/A11.5 $1.40 6/15/2023675,400 shares $1.08 million -0.3%N/A21.5 $1.60 5/31/2023677,700 shares $1.19 million -0.3%N/A23.6 $1.76 5/15/2023679,900 shares $1.23 million -2.7%N/A22 $1.81 4/30/2023698,800 shares $1.41 million +1.5%N/A19 $2.02 4/15/2023688,600 shares $1.36 million -0.2%N/A16.8 $1.97 3/31/2023690,100 shares $1.24 million -5.7%N/A16.5 $1.79 3/15/2023731,600 shares $1.51 million -0.4%N/A16 $2.07FREE investing Class TOMORROW + 2 FREE Bonuses (Ad)Over the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stocks that outperform the market. It helps me understand which stocks are worth investing in now…AND which ones you should avoid at all costs! Tomorrow, during my LIVE intro to investing class online, my team will show you how exactly how it works[YES, I'D LIKE TO REGISTER FOR CHARLES PAYNE'S UPCOMING INTRO TO INVESTING CLASS NOW!] 2/28/2023734,500 shares $1.47 million -3.0%N/A15.7 $2.00 2/15/2023757,400 shares $1.70 million +3.8%N/A16 $2.25 1/31/2023729,800 shares $1.16 million -3.8%N/A16.1 $1.59 1/15/2023758,400 shares $1.21 million -3.9%N/A18.8 $1.59 12/30/2022789,400 shares $1.09 million -5.2%N/A20 $1.38 12/15/2022832,400 shares $1.27 million -3.5%N/A23.6 $1.53 11/30/2022862,200 shares $1.69 million -0.6%N/A21.1 $1.96 11/15/2022867,500 shares $1.87 million -0.5%N/A11 $2.16 10/31/2022871,500 shares $1.86 million -1.0%N/A11.3 $2.13 10/15/2022880,000 shares $1.74 million -0.7%N/A11 $1.98 9/30/2022886,000 shares $1.80 million -4.1%N/A10.7 $2.03 9/15/2022924,100 shares $1.98 million +10.2%N/A10.6 $2.14 8/31/2022838,400 shares $1.97 million -0.6%N/A9.8 $2.35 8/15/2022843,200 shares $2.16 million -3.0%N/A18.6 $2.56 7/31/2022869,600 shares $2.19 million +1.1%N/A16.8 $2.52 7/15/2022859,800 shares $1.96 million -4.3%N/A16.3 $2.28 6/30/2022898,600 shares $2.15 million -3.2%N/A13.4 $2.39 6/15/2022928,400 shares $2.38 million -4.5%N/A12.8 $2.56 5/31/2022971,700 shares $2.80 million -2.8%N/A11.9 $2.88 5/15/20221,000,000 shares $2.92 million -2.0%5.7%11.4 $2.92 4/30/20221,020,000 shares $3.01 million +2.0%5.9%10.7 $2.95 4/15/20221,000,000 shares $3.12 million +2.2%5.7%9.2 $3.12 3/31/2022978,200 shares $3.84 million +5.3%5.6%8.7 $3.93 3/15/2022928,800 shares $2.50 million -4.5%5.3%8.5 $2.69 2/28/2022972,900 shares $2.84 million -2.7%5.6%9.2 $2.92 2/15/20221,000,000 shares $3.06 million +0.9%5.7%9.4 $3.06 1/31/2022991,500 shares $2.54 million -9.0%5.7%9 $2.56 1/15/20221,090,000 shares $4.43 million +0.9%6.3%10 $4.06 12/31/20211,080,000 shares $4.20 million -1.8%6.2%11.1 $3.89 12/15/20211,100,000 shares $4.55 million +5.8%6.3%11.1 $4.14 11/30/20211,040,000 shares $4.13 million +4.0%6.0%9.9 $3.97 11/15/20211,000,000 shares $4.48 million -3.9%5.7%8.4 $4.48 10/29/20211,040,000 shares $4.46 million -4.6%N/A8.2 $4.29 10/15/20211,090,000 shares $4.98 million -3.5%N/A7 $4.57 9/30/20211,130,000 shares $5.18 million -8.1%N/A6.2 $4.58 9/15/20211,230,000 shares $6.14 million -2.4%N/A6.1 $4.99 8/31/20211,260,000 shares $6.25 million +10.5%N/A5.2 $4.96 8/13/20211,140,000 shares $5.38 million -2.6%N/A2.6 $4.72 7/30/20211,170,000 shares $6.46 million +17.4%N/A2.6 $5.52 7/15/2021996,400 shares $4.80 million +2.5%N/A2.3 $4.82 6/30/2021972,400 shares $4.75 million +4.6%N/A2.1 $4.88 6/15/2021929,500 shares $4.86 million +70.7%N/A1.9 $5.23 5/28/2021544,600 shares $2.97 million +54.2%N/A1.2 $5.46 5/14/2021353,200 shares $1.36 million +15.6%N/A1 $3.86 4/30/2021305,500 shares $1.31 million +26.7%N/A0.5 $4.29 4/15/2021241,200 shares $979,272.00 -0.7%N/A0.3 $4.06 3/31/2021243,000 shares $991,440.00 +25.7%N/A0.3 $4.08 3/15/2021193,400 shares $937,990.00 -38.4%N/A0.2 $4.85 2/26/2021314,100 shares $1.52 million -11.1%N/A0.4 $4.85 2/12/2021353,100 shares $2.06 million +90.2%N/A0.4 $5.84FREE investing Class TOMORROW + 2 FREE Bonuses (Ad)Over the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stocks that outperform the market. It helps me understand which stocks are worth investing in now…AND which ones you should avoid at all costs! Tomorrow, during my LIVE intro to investing class online, my team will show you how exactly how it works[YES, I'D LIKE TO REGISTER FOR CHARLES PAYNE'S UPCOMING INTRO TO INVESTING CLASS NOW!] 1/29/2021185,700 shares $768,798.00 +82.6%N/A0.3 $4.14 1/15/2021101,700 shares $441,378.00 No ChangeN/A0.2 $4.34 11/30/202013,300 shares $56,126.00 -69.8%N/A0 $4.22 11/15/202044,000 shares $182,600.00 -7.2%N/A0.1 $4.15 10/30/202047,400 shares $203,346.00 -74.2%N/A0 $4.29 10/15/2020183,700 shares $791,747.00 -33.7%N/A0 $4.31 9/30/2020277,100 shares $1.22 million -31.1%N/A0 $4.41 9/15/2020402,000 shares $1.74 million -37.5%N/A0 $4.34 8/31/2020643,400 shares $2.79 million -83.2%N/A0 $4.34 8/14/20203,820,000 shares $20.15 million -72.3%N/A0.1 $5.27 7/31/202013,770,000 shares $110.53 million -3.5%N/A0.4 $8.03 7/15/202014,270,000 shares $103.46 million +118.9%N/A0.4 $7.25 6/30/20206,520,000 shares $72.37 million +37.0%N/A0.2 $11.10 6/15/20204,760,000 shares $22.51 million -29.5%N/A0.2 $4.73 5/29/20206,750,000 shares $31.79 million +163.7%N/A0.5 $4.71 5/15/20202,560,000 shares $12.57 million +806.5%N/A0.2 $4.91 4/30/2020282,400 shares $946,040.00 -54.8%N/A0 $3.35 4/15/2020625,200 shares $2.19 million +73.5%N/A0.3 $3.50 3/31/2020360,300 shares $1.10 million -61.2%N/A0.3 $3.06 3/13/2020927,600 shares $2.13 million +3.6%N/A3 $2.30 2/28/2020895,700 shares $5.37 million -11.3%N/A5.8 $6.00 2/14/20201,010,000 shares $7.58 million +13.9%N/A7.3 $7.50 1/31/2020886,700 shares $6.47 million +25.4%N/A7.1 $7.30 1/15/2020707,000 shares $5.87 million +3.2%N/A5.6 $8.30 12/31/2019685,300 shares $5.28 million +287.6%N/A7.9 $7.70 PPBT Short Interest - Frequently Asked Questions What is Purple Biotech's current short interest? Short interest is the volume of Purple Biotech shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 19,500 shares of PPBT short. 1.08% of Purple Biotech's shares are currently sold short. Learn More on Purple Biotech's current short interest. What is a good short interest percentage for Purple Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.08% of Purple Biotech's floating shares are currently sold short. Is Purple Biotech's short interest increasing or decreasing? Purple Biotech saw a increase in short interest in October. As of October 31st, there was short interest totaling 19,500 shares, an increase of 8.3% from the previous total of 18,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Purple Biotech's float size? Purple Biotech currently has issued a total of 1,330,000 shares. Some of Purple Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Purple Biotech currently has a public float of 1,800,000 shares. How does Purple Biotech's short interest compare to its competitors? 1.08% of Purple Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Purple Biotech: NLS Pharmaceutics Ltd. (1.27%), PharmaCyte Biotech, Inc. (0.87%), Mannatech, Incorporated (0.19%), ProPhase Labs, Inc. (0.65%), Sensei Biotherapeutics, Inc. (1.18%), ImmunoPrecise Antibodies Ltd. (3.05%), NRx Pharmaceuticals, Inc. (8.64%), Aspira Women's Health Inc. (4.86%), Turnstone Biologics Corp. (2.69%), Avalo Therapeutics, Inc. (0.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Purple Biotech stock? Short selling PPBT is an investing strategy that aims to generate trading profit from Purple Biotech as its price is falling. PPBT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Purple Biotech? A short squeeze for Purple Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPBT, which in turn drives the price of the stock up even further. How often is Purple Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPBT, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies NLS Pharmaceutics Short Interest Data PharmaCyte Biotech Short Interest Data Mannatech Short Interest Data ProPhase Labs Short Interest Data Sensei Biotherapeutics Short Interest Data ImmunoPrecise Antibodies Short Interest Data NRx Pharmaceuticals Short Interest Data Aspira Women's Health Short Interest Data Turnstone Biologics Short Interest Data Avalo Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPBT) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | SponsoredMy favorite credit card just increased its sign-up bonusTired of getting average credit card rewards? This credit card just increased its sign-up bonus to 75,000 bonu...Card Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Purple Biotech Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Purple Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.